General Gynecology
WHO updates recommendations to guide family planning decisions.
24 Nov, 2022 | 13:38h | UTCNews Release: WHO updates recommendations to guide family planning decisions – World Health Organization
Family planning: A global handbook for providers – World Health Organization (PDF)
Commentary on Twitter (thread – click for more)
👉WHO releases important updates to its Family Planning Handbook 🔖
⏭providing health workers and policymakers with the most updated information on contraceptive options.
Know more:🔗https://t.co/UhC1BFca2r pic.twitter.com/LQEtm3wmbZ
— World Health Organization (WHO) (@WHO) November 15, 2022
Cohort Study | Demographic, reproductive, and medical risk factors for intrauterine device expulsion.
21 Nov, 2022 | 13:57h | UTC
M-A | Efficacy and safety of treatments for different stages of syphilis.
18 Nov, 2022 | 13:20h | UTC
Cohort Study | Premenopausal bilateral oophorectomy linked to increased risk of Parkinsonism and Parkinson Disease.
11 Nov, 2022 | 12:56h | UTCNews Release: Removal of Both Ovaries in Younger Women Associated with Increased Risk of Parkinson’s – Discovery’s Edge
Cohort Study | Association of hormone therapy with depression during menopause.
9 Nov, 2022 | 12:17h | UTCCommentaries:
Expert reaction to study looking at HRT and depression during the menopause – Science Media Centre
Commentary on Twitter
Systemic hormone therapy (HT) before and during menopause is associated with higher risk of depression, especially in the years immediately after initiation; locally administered HT is associated with lower risk of depression for women ≥54 years. https://t.co/8k44K8SVtp
— JAMA Network Open (@JAMANetworkOpen) November 1, 2022
Cohort Study | Menstrual cycle regularity and length across the reproductive lifespan and risk of cardiovascular disease.
8 Nov, 2022 | 11:54h | UTCCommentary: Irregular, Long Menstrual Cycles Up Risk for Cardiovascular Disease – HealthDay
Commentary on Twitter
Irregular and long menstrual cycles across a woman’s reproductive lifespan may identify women with a higher risk of cardiovascular disease, even after accounting for established CVD risk factors. #OAResearch #OAWeek https://t.co/BxNveNAqg5
— JAMA Network Open (@JAMANetworkOpen) October 29, 2022
Study | The future risk of cervical precancer among HPV–negative women is increased with a history of HPV–positive results.
1 Nov, 2022 | 12:13h | UTC
SR | Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.
31 Oct, 2022 | 13:56h | UTC
The bleeding cervical cancer patient: systematic approach and management.
26 Oct, 2022 | 14:30h | UTCThe Bleeding Cervical Cancer Patient: Systematic Approach and Management – emDocs
Conservative interventions for treating urinary incontinence in women: an overview of Cochrane systematic reviews.
24 Oct, 2022 | 14:13h | UTC
Cohort Study | Women with schizophrenia-spectrum disorders are at increased risk of relapse after menopause.
24 Oct, 2022 | 13:59h | UTC
Commentary on Twitter
cohort study: Starting at age 45–50, women were consistently more often hospitalized for psychosis than their male peers. Women ≥45 had significantly higher aHRs than women <45 at antipsychotic monotherapy >0.6 DDDs/day, and than men at >1.1 DDDs/day https://t.co/YYINatGD0O pic.twitter.com/7xWmAnt72q
— P𝘧OL (@psychopharmacol) October 7, 2022
Cohort Study | Systemic or vaginal hormone therapy after early breast cancer.
24 Oct, 2022 | 14:00h | UTCNews Release: Hormone replacement therapy doesn’t lead to breast cancer reoccurrence – Oxford University Press
Commentaries:
Hormone Replacement Therapy Won’t Raise Recurrence Rate for Breast Cancer Survivors – HealthDay
RCT | A telemedicine model for abortion in South Africa.
21 Oct, 2022 | 12:51h | UTCA telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
News Release: Telemedicine can give vulnerable women access to safe medical abortions – Karolinska Institutet
Commentaries on Twitter
Researchers report that their telemedicine model for medical #abortion—with uterine palpation as the sole in-person component—was non-inferior to standard care in a low-resource setting. https://t.co/kUMVxYBrI9 pic.twitter.com/sPjgxsB1bK
— The Lancet (@TheLancet) August 30, 2022
Medical #abortion can be carried out safely and effectively via #telemedicine, finds an RCT published in @TheLancet by Margit Endler and colleagues at KI & @UCT_news. This method can potentially reduce the number of unsafe abortions in resource-poor areas. https://t.co/UoNPnD23Hp pic.twitter.com/ac0mvyaJeU
— Karolinska Institutet (@karolinskainst) September 7, 2022
Note: medical abortion is not a legalized procedure in Brazil.
RCT | Expectant vs. medical management for retained products of conception after medical termination of pregnancy.
21 Oct, 2022 | 12:50h | UTCExpectant vs medical management for retained products of conception after medical termination of pregnancy: a randomized controlled study – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)
Commentary on Twitter
Expectant vs medical management for retained products of conception after medical termination of pregnancy: a randomized controlled study https://t.co/UkEoWUHiCt pic.twitter.com/4EnWyeN4LM
— AJOG (@AJOG_thegray) October 16, 2022
Note: medical abortion is not a legalized procedure in Brazil.
M-A | Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome.
18 Oct, 2022 | 12:37h | UTC
RCT | In abortion surgery, Esketamine plus Propofol can reduce hypotension compared to Fentanyl plus Propofol.
14 Oct, 2022 | 13:58h | UTCCommentary: Esketamine as an adjunct with propofol and fentanyl to avoid perioperative hypotension – Physician’s Weekly
Systematic Review | Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency.
13 Oct, 2022 | 13:39h | UTCSummary: Which hormonal therapy works better for women with early failure of the ovaries? – Cochrane Library
Commentary on Twitter
What is the best combination of #hormones that would allow women to have a baby after they suffered from early failure of the ovaries?
Based on limited #evidence from 3 small studies, we were unable to draw any clear conclusions https://t.co/krgfRi9VT3@CochraneLibrary pic.twitter.com/o9dN96E2zP
— Cochrane Gynaecology & Fertility (@CochraneCGF) October 7, 2022
Guideline Summary | Diagnostic stewardship for urinary tract infection.
11 Oct, 2022 | 13:37h | UTCOriginal Guideline: Optimal Urine Culture Diagnostic Stewardship Practice—Results from an Expert Modified-Delphi Procedure – Clinical Infectious Diseases
Secondary prevention of cervical cancer | ASCO resource–stratified guideline update.
6 Oct, 2022 | 13:44h | UTC
Cohort Study | Predicting major complications in patients undergoing laparoscopic and open hysterectomy for benign indications.
6 Oct, 2022 | 13:42h | UTCNews Release: Easy-to-use tool predicts complications in patients undergoing hysterectomy for benign disease
Commentary: Models Predicting Complications of Hysterectomy Developed – HealthDay
Commentary on Twitter
Researchers have developed prediction tools to guide shared decision-making for people with benign conditions considering either laparoscopic or open abdominal hysterectomy: https://t.co/SVNeM4L85b@QMUL @TheBSGE #OBGYNtwitter pic.twitter.com/oHz1Po0eJB
— CMAJ (@CMAJ) October 4, 2022
RCT | Self-cut vs. Mesh-Kit titanium-coated polypropylene Mesh for transvaginal treatment of severe pelvic organ prolapse.
30 Sep, 2022 | 12:38h | UTCCommentary: Self-Cut Mesh Noninferior for Pelvic Organ Prolapse Procedure – HealthDay
Systematic Review | Impact of residual disease in women with advanced epithelial ovarian cancer after primary surgery.
30 Sep, 2022 | 12:28h | UTC
M-A | Carbon dioxide laser vs. vaginal estrogen for genitourinary syndrome of menopause.
29 Sep, 2022 | 13:24h | UTC
Commentary on Twitter
Vaginal laser and vaginal estrogen therapy showed similar improvement in genitourinary symptoms in this systematic review and meta-analysis of RCTs. #Research https://t.co/PpAf77CqKS
— JAMA Network Open (@JAMANetworkOpen) September 21, 2022
RCT | Immunogenicity and safety of one-dose human papillomavirus vaccine vs. two or three doses.
29 Sep, 2022 | 13:21h | UTCInvited Commentary: HPV vaccines: when one plus one equals three – The Lancet Global Health
Related:
RCT: Single-dose HPV vaccination found effective among young African women.
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
Opinion: A Single-dose HPV Vaccine Would Have a Big Impact on Cancer Prevention
Another Observational Study Suggests One Dose of HPV Vaccine may be Enough
Another Study Suggesting One Dose of HPV Vaccine may be Effective for Prevention of Cervical Cancer
Large Observational Study Suggests One Dose of HPV Vaccine May Be as Effective as Three
USPSTF Recommendation Statement | Screening for Syphilis infection in nonpregnant adolescents and adults.
28 Sep, 2022 | 13:52h | UTCEditorial:
Resurgence of Syphilis in the US—USPSTF Reaffirms Screening Guidelines – JAMA Dermatology
The Critical Need to Modernize Syphilis Screening – JAMA
Screening for Syphilis in Nonpregnant Adults and Adolescents – JAMA Network Open
JAMA Patient Page: Screening for Syphilis
Author Interview: USPSTF Recommendation: Syphilis Screening in Nonpregnant Adolescents and Adults
Commentary: USPSTF Recommends Syphilis Screening for At-Risk Persons – HealthDay